Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veysel Cam

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical Rheumatology|August 15, 2023
Biologic drugs in the treatment of juvenile dermatomyositis: a literature reviewSeher Sener, Veysel Cam, Seza Ozen, et al.
Seminars in Arthritis and Rheumatism|March 5, 2024
Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literatureSeher Sener, Veysel Cam, Seza Ozen, et al.
Paediatric Drugs|May 28, 2024
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An UpdateDilara Unal, Veysel Cam, Hulya Ercan Emreol, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 29, 2023
Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published DataEzgi Deniz Batu, Seher Sener, Veysel Cam, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|June 9, 2021
Oxidative Stress in Intoxıcation Type Inborn Errors of Metabolism using Thiol-Disulfide RatioVeysel Cam, Asburce Olgac, Mustafa Kilic, et al.
Scientific Reports|July 2, 2025
Closed circuit artificial ıntelligence model named morgaf for childhood onset systemic lupus erythematosus diagnosisEmil Aliyev, Yagizhan Ugur, Veysel Cam, et al.
Clinical Rheumatology|April 29, 2024
Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritisSeher Sener, Emil Aliyev, Ezgi Deniz Batu, et al.
The Journal of Rheumatology|January 15, 2026
How Physicians Manage Colchicine-Resistant FMF: Insights from a Multinational Survey in High-Prevalence CountriesVeysel Cam, Dilara Unal, Erdal Sag, et al.
Rheumatology (Oxford, England)|March 24, 2023
Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean feverSeher Sener, Veysel Cam, Ezgi Deniz Batu, et al.
Clinical Rheumatology|November 27, 2023
Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?Ezgi Deniz Batu, Seher Sener, Zeynep Balık, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Rheumatology|August 15, 2023
Biologic drugs in the treatment of juvenile dermatomyositis: a literature reviewSeher Sener, Veysel Cam, Seza Ozen, et al.
Seminars in Arthritis and Rheumatism|March 5, 2024
Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literatureSeher Sener, Veysel Cam, Seza Ozen, et al.
Paediatric Drugs|May 28, 2024
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An UpdateDilara Unal, Veysel Cam, Hulya Ercan Emreol, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 29, 2023
Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published DataEzgi Deniz Batu, Seher Sener, Veysel Cam, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|June 9, 2021
Oxidative Stress in Intoxıcation Type Inborn Errors of Metabolism using Thiol-Disulfide RatioVeysel Cam, Asburce Olgac, Mustafa Kilic, et al.
Scientific Reports|July 2, 2025
Closed circuit artificial ıntelligence model named morgaf for childhood onset systemic lupus erythematosus diagnosisEmil Aliyev, Yagizhan Ugur, Veysel Cam, et al.
Clinical Rheumatology|April 29, 2024
Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritisSeher Sener, Emil Aliyev, Ezgi Deniz Batu, et al.
The Journal of Rheumatology|January 15, 2026
How Physicians Manage Colchicine-Resistant FMF: Insights from a Multinational Survey in High-Prevalence CountriesVeysel Cam, Dilara Unal, Erdal Sag, et al.
Rheumatology (Oxford, England)|March 24, 2023
Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean feverSeher Sener, Veysel Cam, Ezgi Deniz Batu, et al.
Clinical Rheumatology|November 27, 2023
Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?Ezgi Deniz Batu, Seher Sener, Zeynep Balık, et al.
Pageof 3